Latest Migraine surgery Stories

Migraine headaches are a drain "” not only on the estimated 30 million Americans who suffer from them, but on the economy, too. Because pain and other symptoms caused by migraine headaches can be quite severe, it is projected that nearly $13 billion is spent every year in headache treatment and loss of time from work, which no one can afford these days. But according to a new study in Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic...

JENA, Germany, May 12 /PRNewswire/ -- Occlutech, the leading European developer of septum occluders, today announced that it has obtained CE mark approval for its new generation ASD and PFO occluders, the Figulla Flex. The Figulla Flex ASD and PFO occluders encompass a new innovative delivery system, making the use of a threaded hub unnecessary. The implantation of the occluder is facilitated by the ability of the delivery system to allow a 45 degree angle before release. The...

A simple procedure may be the key to relief for some who suffer from frequent and severe migraine headaches.In a new study, researchers found significant improvement of migraines following catheter-based closure of the patent foramen ovale (PFO) -- a slight opening in the wall between the heart's right and left atria. Each of us has a PFO in the womb to divert blood away from the lungs, but it closes for three out of four people after birth, researchers said.Previous studies have already...

Reducing the frequency and severity of disabling migraines is crucial for quality of life. A new study, published in the February 2009 issue of JACC: Cardiovascular Interventions, finds significant improvement of migraine following catheter-based closure of patent foramen ovale (PFO)"”a slight opening in the wall between the right and left atria.These findings confirm those of previous observational studies, which consistently show that when a PFO is closed"”whether it's following a...

By Anne Godlasky Headaches distract. Migraines can debilitate. Nearly 30million Americans suffer from the throbbing pain, costing employers about $13 billion a year from missed workdays and impaired work function, according to research reported in the Archives of Internal Medicine. "You can be out for three days -- lie there and not move, feel nauseous but not throw up -- it's incapacitating," says Jeanne Safer, 61, of New York, a psychotherapist who has had regular migraines for about a...

NMT Medical, a medical technology company, has completed patient enrollment in its pivotal patent foramen ovale/stroke clinical trial, Closure I. NMT believes that it is the first company to complete enrollment of a prospective, multi-center, randomized, controlled study that examines the potential relationship between patent foramen ovale (PFO) and stroke and transient ischemic attacks (TIA). The company also believes it will be first to submit a pre-market approval application to the FDA...

NMT Medical, Inc. (NASDAQ: NMTI) announced today that the Company has completed patient enrollment in its pivotal patent foramen ovale (PFO)/stroke clinical trial, CLOSURE I. NMT believes it is the first company to complete enrollment of a prospective, multi-center, randomized, controlled study that examines the potential relationship between PFO and stroke and transient ischemic attacks (TIA). The Company also believes it will be first to submit a premarket approval (PMA) application to the...

A U.S. drug maker said two Phase III clinical trials show Botox injections can help prevent chronic migraines. Allergan Inc. said it hopes to file an application with the U.S. Food and Drug Administration for the use of Botox in patients with chronic migraines by the middle of next year after full data results are presented. The Wall Street Journal said some researchers were surprised by the findings. The American Academy of Neurology earlier this year advised physicians that, based on...

Medtronic, Inc. (NYSE: MDT) today announced that data from a multi-center, prospective, randomized, single-blinded, controlled investigational study using its neurostimulation system to stimulate the occipital nerves as a potential approach to treating medically refractory chronic migraines will be presented during a late-breaking session at the annual scientific meeting of the American Headache Society (AHS) tomorrow in Boston. This study, called Occipital Nerve Stimulation for the Treatment...

Shawnee Mission Medical Center will showcase a procedure that can repair a hole in the heart without invasive surgery in a live Webcast on www.OR-Live.com July 12, 6:30 PM EDT. Cardiologist Paul H. Kramer, MD, of Kramer & Crouse Cardiology, will use a closure device to seal a congenital hole in the heart, a condition also known as patent foramen ovale (PFO), without open-heart surgery. Kramer is a national leader in the innovation of this procedure and was the first cardiologist in the...